Permanent and panerythroid correction of murine β thalassemia by multiple lentiviral integration in hematopoietic stem cells

Suzan Imren, Emmanuel Payen, Karen A. Westerman, Robert Pawliuk, Mary E. Fabry, Connie J. Eaves, Benjamin Cavilla, Louis D. Wadsworth, Yves Beuzard, Eric E. Bouhassira, Robert Russell, Irving M. London, Ronald L. Nagel, Philippe Leboulch, R. Keith Humphries

Research output: Contribution to journalArticle

155 Citations (Scopus)

Abstract

Achieving long-term pancellular expression of a transferred gene at therapeutic level in a given hematopoietic lineage remains an important goal of gene therapy. Advances have recently been made in the genetic correction of the hemoglobinopathies by means of lentiviral vectors and large locus control region (LCR) derivatives. However, panerythroid β globin gene expression has not yet been achieved in β thalassemic mice because of incomplete transduction of the hematopoietic stem cell compartment and position effect variegation of proviruses integrated at a single copy per genome. Here, we report the permanent, panerythroid correction of severe β thalassemia in mice, resulting from a homozygous deletion of the β major globin gene, by transplantation of syngeneic bone marrow transduced with an HIV-1-derived [β globin gene/LCR] lentiviral vector also containing the Rev responsive element and the central polypurine tract/DNA flap. The viral titers produced were high enough to achieve transduction of virtually all of the hematopoietic stem cells in the graft with an average of three integrated proviral copies per genome in all transplanted mice; the transduction was sustained for >7 months in both primary and secondary transplants, at which time ≈95% of the red blood cells in all mice contained human β globin contributing to 32 ± 4% of all β-like globin chains, Hematological parameters approached complete phenotypic correction, as assessed by hemoglobin levels and reticulocyte and red blood cell counts. All circulating red blood cells became and remained normocytic and normochromic, and their density was normalized. Free α globin chains were completely cleared from red blood cell membranes, splenomegaly abated, and iron deposit was almost eliminated in liver sections. These findings indicate that virtually complete transduction of the hematopoietic stem cell compartment can be achieved by high-titer lentiviral vectors and that position effect variegation can be mitigated by multiple events of proviral integration to yield balanced, panerythroid expression. These results provide a solid foundation for the initiation of human clinical trials in β thalassemia patients.

Original languageEnglish (US)
Pages (from-to)14380-14385
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume99
Issue number22
DOIs
StatePublished - Oct 29 2002

Fingerprint

Thalassemia
Globins
Hematopoietic Stem Cells
Chromosomal Position Effects
Locus Control Region
Erythrocytes
Genome
Genes
env Genes
Transplants
Proviruses
Hemoglobinopathies
Erythrocyte Count
Reticulocytes
Splenomegaly
Bone Marrow Transplantation
Genetic Therapy
HIV-1
Hemoglobins
Iron

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Permanent and panerythroid correction of murine β thalassemia by multiple lentiviral integration in hematopoietic stem cells. / Imren, Suzan; Payen, Emmanuel; Westerman, Karen A.; Pawliuk, Robert; Fabry, Mary E.; Eaves, Connie J.; Cavilla, Benjamin; Wadsworth, Louis D.; Beuzard, Yves; Bouhassira, Eric E.; Russell, Robert; London, Irving M.; Nagel, Ronald L.; Leboulch, Philippe; Humphries, R. Keith.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 99, No. 22, 29.10.2002, p. 14380-14385.

Research output: Contribution to journalArticle

Imren, S, Payen, E, Westerman, KA, Pawliuk, R, Fabry, ME, Eaves, CJ, Cavilla, B, Wadsworth, LD, Beuzard, Y, Bouhassira, EE, Russell, R, London, IM, Nagel, RL, Leboulch, P & Humphries, RK 2002, 'Permanent and panerythroid correction of murine β thalassemia by multiple lentiviral integration in hematopoietic stem cells', Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 22, pp. 14380-14385. https://doi.org/10.1073/pnas.212507099
Imren, Suzan ; Payen, Emmanuel ; Westerman, Karen A. ; Pawliuk, Robert ; Fabry, Mary E. ; Eaves, Connie J. ; Cavilla, Benjamin ; Wadsworth, Louis D. ; Beuzard, Yves ; Bouhassira, Eric E. ; Russell, Robert ; London, Irving M. ; Nagel, Ronald L. ; Leboulch, Philippe ; Humphries, R. Keith. / Permanent and panerythroid correction of murine β thalassemia by multiple lentiviral integration in hematopoietic stem cells. In: Proceedings of the National Academy of Sciences of the United States of America. 2002 ; Vol. 99, No. 22. pp. 14380-14385.
@article{28c301c5f7634f7bbe085d3398996b16,
title = "Permanent and panerythroid correction of murine β thalassemia by multiple lentiviral integration in hematopoietic stem cells",
abstract = "Achieving long-term pancellular expression of a transferred gene at therapeutic level in a given hematopoietic lineage remains an important goal of gene therapy. Advances have recently been made in the genetic correction of the hemoglobinopathies by means of lentiviral vectors and large locus control region (LCR) derivatives. However, panerythroid β globin gene expression has not yet been achieved in β thalassemic mice because of incomplete transduction of the hematopoietic stem cell compartment and position effect variegation of proviruses integrated at a single copy per genome. Here, we report the permanent, panerythroid correction of severe β thalassemia in mice, resulting from a homozygous deletion of the β major globin gene, by transplantation of syngeneic bone marrow transduced with an HIV-1-derived [β globin gene/LCR] lentiviral vector also containing the Rev responsive element and the central polypurine tract/DNA flap. The viral titers produced were high enough to achieve transduction of virtually all of the hematopoietic stem cells in the graft with an average of three integrated proviral copies per genome in all transplanted mice; the transduction was sustained for >7 months in both primary and secondary transplants, at which time ≈95{\%} of the red blood cells in all mice contained human β globin contributing to 32 ± 4{\%} of all β-like globin chains, Hematological parameters approached complete phenotypic correction, as assessed by hemoglobin levels and reticulocyte and red blood cell counts. All circulating red blood cells became and remained normocytic and normochromic, and their density was normalized. Free α globin chains were completely cleared from red blood cell membranes, splenomegaly abated, and iron deposit was almost eliminated in liver sections. These findings indicate that virtually complete transduction of the hematopoietic stem cell compartment can be achieved by high-titer lentiviral vectors and that position effect variegation can be mitigated by multiple events of proviral integration to yield balanced, panerythroid expression. These results provide a solid foundation for the initiation of human clinical trials in β thalassemia patients.",
author = "Suzan Imren and Emmanuel Payen and Westerman, {Karen A.} and Robert Pawliuk and Fabry, {Mary E.} and Eaves, {Connie J.} and Benjamin Cavilla and Wadsworth, {Louis D.} and Yves Beuzard and Bouhassira, {Eric E.} and Robert Russell and London, {Irving M.} and Nagel, {Ronald L.} and Philippe Leboulch and Humphries, {R. Keith}",
year = "2002",
month = "10",
day = "29",
doi = "10.1073/pnas.212507099",
language = "English (US)",
volume = "99",
pages = "14380--14385",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "22",

}

TY - JOUR

T1 - Permanent and panerythroid correction of murine β thalassemia by multiple lentiviral integration in hematopoietic stem cells

AU - Imren, Suzan

AU - Payen, Emmanuel

AU - Westerman, Karen A.

AU - Pawliuk, Robert

AU - Fabry, Mary E.

AU - Eaves, Connie J.

AU - Cavilla, Benjamin

AU - Wadsworth, Louis D.

AU - Beuzard, Yves

AU - Bouhassira, Eric E.

AU - Russell, Robert

AU - London, Irving M.

AU - Nagel, Ronald L.

AU - Leboulch, Philippe

AU - Humphries, R. Keith

PY - 2002/10/29

Y1 - 2002/10/29

N2 - Achieving long-term pancellular expression of a transferred gene at therapeutic level in a given hematopoietic lineage remains an important goal of gene therapy. Advances have recently been made in the genetic correction of the hemoglobinopathies by means of lentiviral vectors and large locus control region (LCR) derivatives. However, panerythroid β globin gene expression has not yet been achieved in β thalassemic mice because of incomplete transduction of the hematopoietic stem cell compartment and position effect variegation of proviruses integrated at a single copy per genome. Here, we report the permanent, panerythroid correction of severe β thalassemia in mice, resulting from a homozygous deletion of the β major globin gene, by transplantation of syngeneic bone marrow transduced with an HIV-1-derived [β globin gene/LCR] lentiviral vector also containing the Rev responsive element and the central polypurine tract/DNA flap. The viral titers produced were high enough to achieve transduction of virtually all of the hematopoietic stem cells in the graft with an average of three integrated proviral copies per genome in all transplanted mice; the transduction was sustained for >7 months in both primary and secondary transplants, at which time ≈95% of the red blood cells in all mice contained human β globin contributing to 32 ± 4% of all β-like globin chains, Hematological parameters approached complete phenotypic correction, as assessed by hemoglobin levels and reticulocyte and red blood cell counts. All circulating red blood cells became and remained normocytic and normochromic, and their density was normalized. Free α globin chains were completely cleared from red blood cell membranes, splenomegaly abated, and iron deposit was almost eliminated in liver sections. These findings indicate that virtually complete transduction of the hematopoietic stem cell compartment can be achieved by high-titer lentiviral vectors and that position effect variegation can be mitigated by multiple events of proviral integration to yield balanced, panerythroid expression. These results provide a solid foundation for the initiation of human clinical trials in β thalassemia patients.

AB - Achieving long-term pancellular expression of a transferred gene at therapeutic level in a given hematopoietic lineage remains an important goal of gene therapy. Advances have recently been made in the genetic correction of the hemoglobinopathies by means of lentiviral vectors and large locus control region (LCR) derivatives. However, panerythroid β globin gene expression has not yet been achieved in β thalassemic mice because of incomplete transduction of the hematopoietic stem cell compartment and position effect variegation of proviruses integrated at a single copy per genome. Here, we report the permanent, panerythroid correction of severe β thalassemia in mice, resulting from a homozygous deletion of the β major globin gene, by transplantation of syngeneic bone marrow transduced with an HIV-1-derived [β globin gene/LCR] lentiviral vector also containing the Rev responsive element and the central polypurine tract/DNA flap. The viral titers produced were high enough to achieve transduction of virtually all of the hematopoietic stem cells in the graft with an average of three integrated proviral copies per genome in all transplanted mice; the transduction was sustained for >7 months in both primary and secondary transplants, at which time ≈95% of the red blood cells in all mice contained human β globin contributing to 32 ± 4% of all β-like globin chains, Hematological parameters approached complete phenotypic correction, as assessed by hemoglobin levels and reticulocyte and red blood cell counts. All circulating red blood cells became and remained normocytic and normochromic, and their density was normalized. Free α globin chains were completely cleared from red blood cell membranes, splenomegaly abated, and iron deposit was almost eliminated in liver sections. These findings indicate that virtually complete transduction of the hematopoietic stem cell compartment can be achieved by high-titer lentiviral vectors and that position effect variegation can be mitigated by multiple events of proviral integration to yield balanced, panerythroid expression. These results provide a solid foundation for the initiation of human clinical trials in β thalassemia patients.

UR - http://www.scopus.com/inward/record.url?scp=0037195091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037195091&partnerID=8YFLogxK

U2 - 10.1073/pnas.212507099

DO - 10.1073/pnas.212507099

M3 - Article

C2 - 12391330

AN - SCOPUS:0037195091

VL - 99

SP - 14380

EP - 14385

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 22

ER -